Patent · US Active

Cell

US11365262B2 · kind B2 · utility

2Cited by
0References
19Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 19, 2016
Grant dateJun 21, 2022
Priority date
Expiry dateAug 11, 2039

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2510/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides a cell which comprises a first chimeric antigen receptor (CAR) and a second CAR, wherein the first and second CARs bind different epitopes on the same ligand. The cell may be used in a method for treating a disease, such as cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.